Gladstone Capital Corporation - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Acumen Pharmaceuticals faces strategic reset with $78.6m cash after Alzheimer’s drug failure

NRx Pharmaceuticals moves toward ketamine sales after FDA approval of domestic injectable product

Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?

Affle 3i to acquire Perion for $420m, but its $228m cash balance changes the deal maths

Read More

General business news

Gladstone Capital boosts investor returns with supplemental dividend: What’s behind the payout?

Discover how Gladstone Capital’s $0.10 supplemental dividend boosts yield and signals confidence amid sector volatility in 2025.

byPallavi Madhiraju

September 15, 2025

web analytics